These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 28177223)
41. Sandwich DNA Hybridization Fluorescence Resonance Energy-Transfer Strategy for miR-122 Detection by Core-Shell Upconversion Nanoparticles. Ren H; Long Z; Shen X; Zhang Y; Sun J; Ouyang J; Na N ACS Appl Mater Interfaces; 2018 Aug; 10(30):25621-25628. PubMed ID: 29969017 [TBL] [Abstract][Full Text] [Related]
42. A novel label-free upconversion fluorescence resonance energy transfer-nanosensor for ultrasensitive detection of protamine and heparin. Long Q; Zhao J; Yin B; Li H; Zhang Y; Yao S Anal Biochem; 2015 May; 477():28-34. PubMed ID: 25721409 [TBL] [Abstract][Full Text] [Related]
43. Labeling and long-term tracking of bone marrow mesenchymal stem cells in vitro using NaYF4:Yb(3+),Er(3+) upconversion nanoparticles. Ma Y; Ji Y; You M; Wang S; Dong Y; Jin G; Lin M; Wang Q; Li A; Zhang X; Xu F Acta Biomater; 2016 Sep; 42():199-208. PubMed ID: 27435964 [TBL] [Abstract][Full Text] [Related]
44. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy. Li TS; Yawata T; Honke K Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005 [TBL] [Abstract][Full Text] [Related]
45. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. Ma X; Zhao Y; Ng KW; Zhao Y Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533 [TBL] [Abstract][Full Text] [Related]
46. Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance. Yhee JY; Song S; Lee SJ; Park SG; Kim KS; Kim MG; Son S; Koo H; Kwon IC; Jeong JH; Jeong SY; Kim SH; Kim K J Control Release; 2015 Jan; 198():1-9. PubMed ID: 25481438 [TBL] [Abstract][Full Text] [Related]
47. Resonance Energy Transfer in Upconversion Nanoplatforms for Selective Biodetection. Su Q; Feng W; Yang D; Li F Acc Chem Res; 2017 Jan; 50(1):32-40. PubMed ID: 27983801 [TBL] [Abstract][Full Text] [Related]
48. An ultrasensitive homogeneous aptasensor for kanamycin based on upconversion fluorescence resonance energy transfer. Li H; Sun DE; Liu Y; Liu Z Biosens Bioelectron; 2014 May; 55():149-56. PubMed ID: 24373954 [TBL] [Abstract][Full Text] [Related]
49. siRNA-mediated silencing of MDR1 reverses the resistance to oxaliplatin in SW480/OxR colon cancer cells. Montazami N; Kheir Andish M; Majidi J; Yousefi M; Yousefi B; Mohamadnejad L; Shanebandi D; Estiar MA; Khaze V; Mansoori B; Baghbani E; Baradaran B Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):98-103. PubMed ID: 26025411 [TBL] [Abstract][Full Text] [Related]
50. Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells. Babu A; Wang Q; Muralidharan R; Shanker M; Munshi A; Ramesh R Mol Pharm; 2014 Aug; 11(8):2720-33. PubMed ID: 24922589 [TBL] [Abstract][Full Text] [Related]
51. A Core-Shell-Satellite Structured Fe Feng L; Yang D; He F; Gai S; Li C; Dai Y; Yang P Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28643467 [TBL] [Abstract][Full Text] [Related]
52. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy. Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077 [TBL] [Abstract][Full Text] [Related]
53. Multiplexed fluorescence resonance energy transfer aptasensor between upconversion nanoparticles and graphene oxide for the simultaneous determination of mycotoxins. Wu S; Duan N; Ma X; Xia Y; Wang H; Wang Z; Zhang Q Anal Chem; 2012 Jul; 84(14):6263-70. PubMed ID: 22816786 [TBL] [Abstract][Full Text] [Related]
54. [Homogeneous immunoassay technology based on near infrared upconversion fluorescence resonance energy transfer]. Song K; Ran YY; Kong XG Guang Pu Xue Yu Guang Pu Fen Xi; 2011 Jan; 31(1):86-90. PubMed ID: 21428063 [TBL] [Abstract][Full Text] [Related]
55. Enhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with ultrasound. Bai M; Shen M; Teng Y; Sun Y; Li F; Zhang X; Xu Y; Duan Y; Du L Oncotarget; 2015 Dec; 6(41):43779-90. PubMed ID: 26575421 [TBL] [Abstract][Full Text] [Related]
56. Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells. Zhang H; Wang J; Cai K; Jiang L; Zhou D; Yang C; Chen J; Chen D; Dou J J Cancer Res Ther; 2012; 8(2):226-31. PubMed ID: 22842366 [TBL] [Abstract][Full Text] [Related]
57. Upconversion nanoparticles based FRET aptasensor for rapid and ultrasenstive bacteria detection. Jin B; Wang S; Lin M; Jin Y; Zhang S; Cui X; Gong Y; Li A; Xu F; Lu TJ Biosens Bioelectron; 2017 Apr; 90():525-533. PubMed ID: 27825886 [TBL] [Abstract][Full Text] [Related]
58. siRNA Targeting of MDR1 Reverses Multidrug Resistance in a Nude Mouse Model of Doxorubicin-resistant Human Hepatocellular Carcinoma. Yang H; Ding R; Tong Z; Huang J; Shen L; Sun YU; Liao J; Yang Z; Hoffman RM; Wang C; Meng X Anticancer Res; 2016 Jun; 36(6):2675-82. PubMed ID: 27272776 [TBL] [Abstract][Full Text] [Related]
59. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Wang C; Cheng L; Liu Z Biomaterials; 2011 Feb; 32(4):1110-20. PubMed ID: 20965564 [TBL] [Abstract][Full Text] [Related]
60. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis. Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]